Three independent discounted-cash-flow-style models value Bioventus Inc. Class A Common Stock every trading day. 0 of 3 currently price BVS above its market price.
| Free Cash Flow model | $-61.89 |
| Excess Profit model | $-62.80 |
| Residual Earnings model | $-0.17 |
| Dividend Discount model | — |
| Piotroski F-Score | 8 / 9 |
| Return on invested capital | +8.9% |
| Net debt / EBITDA | 4.5× |
| Gross margin | +68.3% |
| Revenue CAGR | +3.5% |
| Cash conversion | 2.7× |
| Dividend yield | — |
| Buyback yield | -3.2% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open BVS in StockKitty